SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193805-16-002612
Filing Date
2016-02-16
Accepted
2016-02-16 08:25:36
Documents
1
Group Members
DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.DEERFIELD SPECIAL SITUATIONS INTER

Document Format Files

Seq Description Document Type Size
1 e614592_sc13ga-avalanche.htm SC 13G/A 482379
  Complete submission text file 0001193805-16-002612.txt   484063
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88266 | Film No.: 161423246
SIC: 2836 Biological Products, (No Diagnostic Substances)